ecancer

Advances and treatment strategies for metastatic hormone-sensitive prostate cancer

Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK

5 Feb 2021

Outcomes of black and white men with prostate cancer in an equal access healthcare setting

Kenrick Ng - Senior Specialist Registrar in Medical Oncology, UCL Hospitals, London, UK

5 Feb 2021

OncoAlert and ecancer weekly roundup for January 25 - 31, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

4 Feb 2021

The role of a physician assistant in oncology

Noam Shabani - Dana-Farber Cancer Institute, Boston, USA

3 Feb 2021

Role of PARP inhibitors in treating advanced prostate cancer

Noam Shabani - Dana-Farber Cancer Institute, Boston, USA

3 Feb 2021

OncoAlert and ecancer weekly roundup for January 18 - 24, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

25 Jan 2021

OncoAlert and ecancer weekly roundup for January 11 - 17, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

21 Jan 2021

Cyber knife radiation for prostate cancer

Kelsey Keenan - Perlmutter Cancer Center at NYU Langone Hospital, Long Island, USA

24 Dec 2020

OncoAlert Colloquium Day 5: Genitourinary tumours and social media

Dr McBride, Dr Apolo, Dr Choueiri, Dr Morgan, Dr Agarwal

23 Dec 2020

PARP inhibitors for prostate cancer: What oncology PAs should know

Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA

18 Dec 2020

OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

9 Dec 2020

PARP inhibitors in prostate cancer: A promise delivered

Dr Abhishek Tripathi - Stephenson Cancer Center, Oklahoma City, USA

1 Dec 2020

More from ecancer